Stay updated with breaking news from Alpha Cognition. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Alpha Cognition Inc. announces that it has completed a fourth closing pursuant to its previously announced private placement of units of the Company. Pursuant to the fourth closing, the Company...
The FDA has accepted for review the New Drug Application for ALPHA-1062 for the treatment of mild to moderate Alzheimer disease.
The FDA has accepted for review the New Drug Application for ALPHA-1062 for the treatment of mild to moderate Alzheimer disease.
Alpha Cognition Inc. , a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, is pleased to announce that the U.S. Food and Drug Administration has...
Alpha Cognition Inc. announces that it has completed a third closing pursuant to its previously announced private placement of units of the Company. Pursuant to the third closing, the Company...